CI Falkson
University of North Carolina at Chapel Hill(US)Everett Community College(US)University of Washington(US)Ottawa Hospital(CA)University of Alabama at Birmingham(US)Cancer Research And Biostatistics(US)Mayo Clinic in Arizona(US)Mayo Clinic in Florida(US)Ottawa Hospital Research Institute
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Estrogen and related hormone effects, HER2/EGFR in Cancer Research
Most-Cited Works
- → Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999–2006(2011)216 cited
- → Abstract S5-04: Ten year follow-up of BCIRG-006 comparing doxorubicin plus cyclophosphamide followed by docetaxel (AC→T) with doxorubicin plus cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2+ early breast cancer(2016)149 cited
- Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative Oncology Group Phase II Study (E2E93).(2001)
- → S2-3: NSABP Protocol B-34: A Clinical Trial Comparing Adjuvant Clodronate vs. Placebo in Early Stage Breast Cancer Patients Receiving Systemic Chemotherapy and/or Tamoxifen or No Therapy – Final Analysis.(2011)18 cited
- → Abstract P4-14-19: ONT-380 in the treatment of HER2+ breast cancer central nervous system (CNS) metastases (mets)(2016)7 cited
- →